Basel Medical Group Ltd Ordinary Shares (BMGL) financial statements and ratios from SEC XBRL: revenue $0.0B (TTM), net margin -94.0%, revenue growth 12.6% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (latest FY) | $11.32M |
| Revenue (TTM) | $0.0B |
| Net Margin | -94.0% |
| Return on Equity | -222.3% |
| Debt / Equity | 0.54 |
| Current Ratio | 1.31 |
| Revenue Growth (YoY) | 12.6% |
| EPS Growth (YoY) | -446.2% |
| Price / Book | 1.70 |
| Price / Sales | 0.82 |
| Industry P/E (Healthcare Services) | 25.4 |
| Sector P/E (Healthcare) | 21.9 |
BMGL overview · BMGL earnings · BMGL KPIs · BMGL documents · BMGL ownership · BMGL peers
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.